Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

News anchor shares experience about link between multiple sclerosis and dental mercury fillings

Nashville news anchor (Fox 17) Stacy Case will share her personal experience about the link between multiple sclerosis (MS) and dental mercury fillings on the January 3rd episode of CBS's The Doctors entitled "Dangerous Toxins."

2 Jan 2013

Early problems in processing knowledge-based information linked to Alzheimer's disease

People who study or treat Alzheimer's disease and its earliest clinical stage, mild cognitive impairment (MCI), have focused attention on the obvious short-term memory problems. But a new study suggests that people on the road to Alzheimer's may actually have problems early on in processing semantic or knowledge-based information, which could have much broader implications for how patients function in their lives.

29 Dec 2012

Make palliative care available to Parkinson's patients

A modified version of the Edmonton Symptom Assessment System Scale is quick and effective at assessing patients with late-stage Parkinson's disease, and reveals that they have similar levels of symptoms as their peers with metastatic cancer, show study results from Canada.

28 Dec 2012

New cost-effective, less invasive MRI method for diagnosis of dementia

A new way to use MRI scans may help determine whether dementia is Alzheimer's disease or another type of dementia, according to new research published in the December 26, 2012, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Dec 2012

Implementation of appropriateness criteria required for elective procedures

Many of the most common inpatient surgeries in the United States are performed electively. These surgeries are expected to significantly increase with the enactment of the Affordable Care Act.

27 Dec 2012

Parkinson’s: an interview with Steve Ford, CEO of Parkinson’s UK

Parkinson’s disease is a neurological condition that is caused when brain cells, that produce the chemical messenger dopamine, start to die.

24 Dec 2012

Gene therapy shows promise for severe coronary artery disease

Diagnosed with severe coronary artery disease, a group of patients too ill for or not responding to other treatment options decided to take part in a clinical trial testing angiogenic gene therapy to help rebuild their damaged blood vessels.

21 Dec 2012

FUS RNA binding ability essential for development of Amyotrophic Lateral Sclerosis

Research led by Dr. Udai Pandey, Assistant Professor of Genetics at LSU Health Sciences Center New Orleans, has found that the ability of a protein made by a gene called FUS to bind to RNA is essential to the development of Amyotrophic Lateral Sclerosis (ALS). This discovery identifies a possible therapeutic target for the fatal neurological disease.

20 Dec 2012

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases - amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) - and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.

20 Dec 2012

Metallic probe can detect fibrils from misfolded proteins in real time

Rice University scientists have discovered a new way to look inside living cells and see the insoluble fibrillar deposits associated with Parkinson's disease.

19 Dec 2012

Link between silent stroke and Parkinson's disease

Scientists at The University of Manchester have for the first time identified why a patient who appears outwardly healthy may develop Parkinson's disease.

19 Dec 2012

Transcranial stimulation improves symptoms of Tourette’s

A month of daily transcranial magnetic stimulation targeting the supplemental motor area results in lasting improvements in symptoms of Tourette syndrome, show study findings.

18 Dec 2012

LCSB, AxoGlia receive Michael J. Fox Foundation grant for Parkinson's project

AxoGlia Therapeutics SA, a biopharmaceutical company which drives the development of innovative neural stem/progenitor cell differentiation and neuroprotective therapeutics, today announced that it has been awarded a Rapid Response Innovative Award from The Michael J. Fox Foundation, for a project that is performed in collaboration with the Luxembourg Centre for Systems Biomedicine (LCSB).

15 Dec 2012

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

Amarantus BioScience, Inc., a biotechnology company discovering and developing treatments for diseases associated with protein misfolding and apoptosis, today announced that it has licensed the LymPro Alzheimer's Disease Diagnostic Blood Test (LymPro) from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, Inc.

14 Dec 2012

Researchers question animal models that measure generalized anxiety disorder

Pre-clinical trials - the stage at which medications or therapies are tested on animals like laboratory mice - is a crucial part of drug development. It's only then that scientists can assess benefits and side effects before a drug is administered to patients.

14 Dec 2012

Weill Cornell research team develops new experimental drug therapy to target DLBCL

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell - DLBCL (ABC-DLBCL), remains a major therapeutic challenge.

11 Dec 2012

uniQure commences acute intermittent porphyria Phase I clinical trial

uniQure B.V., a leader in the field of human gene therapy, today announced the start of its Phase I clinical trial in acute intermittent porphyria (AIP) with the treatment of the first patient.

11 Dec 2012

JPND invites proposals from researchers to understand the underlying causes of neurodegenerative diseases

The EU Joint Programme - Neurodegenerative Disease Research (JPND) is inviting calls for proposals from research teams across Europe to increase understanding of the factors that put people at risk of developing neurodegenerative diseases (ND) such as Alzheimer's and also to evaluate health and social care strategies for people living with these debilitating illnesses.

10 Dec 2012

Anti-seizure drug benefits women with severe morning sickness

Good news may be on the horizon for Kate Middleton, Duchess of Cambridge, and other women stricken with severe nausea and vomiting during pregnancy, thanks to the work of a University at Buffalo professor who is conducting research on a drug that is showing success treating pregnant women with this condition.

8 Dec 2012

Boston Scientific’s Precision Spectra Spinal Cord Stimulator System receives CE Mark approval

Boston Scientific Corporation has received CE Mark approval and has begun the European market launch of the Precision Spectra Spinal Cord Stimulator (SCS) System.

7 Dec 2012

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

News anchor shares experience about link between multiple sclerosis and dental mercury fillings

Early problems in processing knowledge-based information linked to Alzheimer's disease

Make palliative care available to Parkinson's patients

New cost-effective, less invasive MRI method for diagnosis of dementia

Implementation of appropriateness criteria required for elective procedures

Parkinson’s: an interview with Steve Ford, CEO of Parkinson’s UK

Gene therapy shows promise for severe coronary artery disease

FUS RNA binding ability essential for development of Amyotrophic Lateral Sclerosis

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Metallic probe can detect fibrils from misfolded proteins in real time

Link between silent stroke and Parkinson's disease

Transcranial stimulation improves symptoms of Tourette’s

LCSB, AxoGlia receive Michael J. Fox Foundation grant for Parkinson's project

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

Researchers question animal models that measure generalized anxiety disorder

Weill Cornell research team develops new experimental drug therapy to target DLBCL

uniQure commences acute intermittent porphyria Phase I clinical trial

JPND invites proposals from researchers to understand the underlying causes of neurodegenerative diseases

Anti-seizure drug benefits women with severe morning sickness

Boston Scientific’s Precision Spectra Spinal Cord Stimulator System receives CE Mark approval

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in